Life AI Net
Home
Archive
Calculators
Directory
Newsletter
Login
English
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Home
Archive
Calculators
Directory
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Login
Home
Archive
Calculators
Directory
More
Live
10x Genomics Blog
Why 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance
10x Genomics Blog
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
10x Genomics News
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
Science Daily Biotech
A rare cancer-fighting plant compound has been decoded
Eli Lilly
Eli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - Stocktwits
Endpoints News
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
Illumina
The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st
Siemens Healthineers
A Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.st
LabCorp
Labcorp and Epic Expand Collaboration for Lab Test Ordering - Clinical Lab Products
FierceBiotech
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
FierceBiotech
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
Eli Lilly
Eli Lilly Price Prediction: This Is Where The Stock Will End This Year - 24/7 Wall St.
10x Genomics Blog
Why 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance
10x Genomics Blog
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
10x Genomics News
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
Science Daily Biotech
A rare cancer-fighting plant compound has been decoded
Eli Lilly
Eli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - Stocktwits
Endpoints News
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
Illumina
The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st
Siemens Healthineers
A Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.st
LabCorp
Labcorp and Epic Expand Collaboration for Lab Test Ordering - Clinical Lab Products
FierceBiotech
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
FierceBiotech
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
Eli Lilly
Eli Lilly Price Prediction: This Is Where The Stock Will End This Year - 24/7 Wall St.
Archive
This story is not available in the archive.